John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
PUT
Fastly Inc
FSLY
$3.65B
| $6.93M | 0.02% |
79,300
-100,400
| -56% | -$8.85M |
|
|
752
CALL
Best Buy
BBY
$18.4B
| $6.91M | 0.02% |
69,200
+43,200
| +166% | +$4.83M |
|
753
Community Health Systems
CYH
$424M
| $6.91M | 0.02% |
929,361
+688,648
| +286% | +$4.87M |
|
754
Array Technologies
ARRY
$704M
| $6.89M | 0.02% |
+159,754
| New | +$6.44M |
|
755
Sportsman's Warehouse
SPWH
$44.5M
| $6.89M | 0.02% |
392,400
-87,169
| -18% | -$1.28M |
|
756
Franklin Templeton
BEN
$17.6B
| $6.88M | 0.02% |
275,336
-1,014,887
| -79% | -$22.7M |
|
|
EGIO
757
DELISTED
Edgio, Inc. Common Stock
EGIO
| $6.88M | 0.02% |
43,080
+27,527
| +177% | +$5.03M |
|
758
Arista Networks
ANET
$237B
| $6.87M | 0.02% |
378,400
+59,728
| +19% | +$946K |
|
759
Magnolia Oil & Gas
MGY
$6.45B
| $6.87M | 0.02% |
972,699
-110,868
| -10% | -$661K |
|
760
MACOM Technology Solutions
MTSI
$19.7B
| $6.86M | 0.02% |
124,674
-145,528
| -54% | -$6.21M |
|
|
NAV
761
DELISTED
Navistar International
NAV
| $6.86M | 0.02% |
+156,012
| New | +$6.8M |
|
|
ICPT
762
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $6.85M | 0.02% |
277,386
+61,480
| +28% | +$2.04M |
|
|
XEC
763
DELISTED
CIMAREX ENERGY CO
XEC
| $6.85M | 0.02% |
182,505
-89,064
| -33% | -$2.85M |
|
764
Frontdoor
FTDR
$5.7B
| $6.84M | 0.02% |
+136,231
| New | +$6.23M |
|
765
CALL
3M
MMM
$92.3B
| $6.83M | 0.02% |
46,764
+43,176
| +1,203% | +$6.13M |
|
766
PUT
Lyft
LYFT
$6.69B
| $6.81M | 0.02% |
138,600
-212,000
| -60% | -$7.71M |
|
767
TransAlta
TAC
$3.83B
| $6.8M | 0.02% |
896,408
+762,823
| +571% | +$5.1M |
|
768
iShares Russell 1000 ETF
IWB
$48.8B
| $6.8M | 0.02% |
32,100
+19,000
| +145% | +$3.79M |
|
769
Truist Financial
TFC
$62.1B
| $6.79M | 0.02% |
+141,687
| New | +$6.41M |
|
|
TBCH
770
Turtle Beach Corp
TBCH
$225M
| $6.78M | 0.02% |
314,820
+128,114
| +69% | +$2.55M |
|
771
PUT
NextEra Energy
NEE
$175B
| $6.74M | 0.02% |
87,400
+81,800
| +1,461% | +$6.12M |
|
|
ODT
772
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $6.74M | 0.02% |
351,028
+37,257
| +12% | +$575K |
|
773
Murphy Oil
MUR
$5.16B
| $6.74M | 0.02% |
+556,660
| New | +$5.53M |
|
774
PAR Technology
PAR
$804M
| $6.73M | 0.02% |
+107,203
| New | +$5.26M |
|
775
AnaptysBio
ANAB
$1.73B
| $6.69M | 0.02% |
311,077
+42,964
| +16% | +$1.04M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.